The Claim

In individuals with autosomal dominant Alzheimer’s disease, the plasma-to-CSF neurofilament light chain ratio is significantly lower during symptomatic stages compared to asymptomatic stages, indicating a change in the transport or clearance dynamics of neurofilament light chain from the central nervous system to the bloodstream as the disease progresses.

Source: Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer’s disease

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
66score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

In people with inherited Alzheimer’s disease, the ratio of neurofilament light chain in blood versus spinal fluid drops significantly when symptoms appear, reflecting a change in how this protein moves from the brain into the bloodstream.

See the scientific wording

In autosomal dominant Alzheimer’s disease, the plasma-to-CSF neurofilament light chain ratio decreases significantly in symptomatic stages, suggesting a potential alteration in the transport or clearance of NfL from the central nervous system to the bloodstream as the disease progresses.

Why this might work

As brain damage worsens in Alzheimer’s disease, nerve cells break down and release a protein called NfL into the fluid around the brain. This protein normally moves from the brain fluid into the bloodstream, but when symptoms appear, this movement slows down. The brain keeps releasing more NfL, but less of it reaches the blood, causing the ratio of NfL in blood to brain fluid to drop.

Supported mechanismbased on 1 study

What the research says

1 study

  1. Study: Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer’s disease

    In people with inherited Alzheimer’s, a marker of brain damage called NfL goes up in both blood and spinal fluid before symptoms start. But once symptoms appear, the spinal fluid level keeps climbing while the blood level stops rising — so the ratio of blood to spinal fluid NfL drops, meaning less of the marker is getting from the brain into the blood.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.